Health Catalyst, Inc.
$1.26
▲
0.86%
2026-04-21 07:15:01
www.healthcatalyst.com
NMS: HCAT
Explore Health Catalyst, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$92.72 M
Current Price
$1.26
52W High / Low
$5.06 / $0.96
Stock P/E
—
Book Value
$3.41
Dividend Yield
—
ROCE
-10.35%
ROE
-58.26%
Face Value
—
EPS
$-2.55
Exp Qtr EPS
—
Sector
Healthcare
Industry
Health Information Services
Employees
1,200
Beta
1.81
Debt / Equity
69.67
Current Ratio
1.89
Quick Ratio
1.89
Forward P/E
6.29
Price / Sales
0.24
Enterprise Value
$148.82 M
EV / EBITDA
-28.8
EV / Revenue
0.48
Rating
Hold
Target Price
$1.96
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Mangoceuticals, Inc. | $0.51 | — | $7.43 M | — | -62.34% | -1.42% | $2.88 / $0.16 | $1.13 |
| 2. | VSee Health, Inc. | $0.24 | — | $11.87 M | — | -476.79% | -5.42% | $2.52 / $0.19 | $-0.33 |
| 3. | HealthEquity, Inc. | $83.22 | 33.83 | $7.04 B | — | 10.16% | 10.19% | $116.65 / $72.76 | $24.79 |
| 4. | Weave Communications, Inc. | $5.47 | — | $430.21 M | — | -24.81% | -37.56% | $11.32 / $4.24 | $1.05 |
| 5. | HealthStream, Inc. | $21.34 | 34.36 | $630.28 M | 0.6% | 5.11% | 5.14% | $34.13 / $19.5 | $11.97 |
| 6. | Privia Health Group, Inc. | $24.08 | 131.66 | $3.02 B | — | 4.27% | 4.03% | $26.51 / $18.77 | $5.96 |
| 7. | Certara, Inc. | $6.19 | — | $989.85 M | — | 1.5% | -0.15% | $15.38 / $5.19 | $6.68 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 74.68 M | 76.32 M | 80.72 M | 79.41 M | 79.61 M | — |
| Operating Profit | 3.26 M | -17.51 M | -8.32 M | -20.17 M | -17.5 M | — |
| Net Profit | -91.03 M | -22.23 M | -40.98 M | -23.74 M | -20.67 M | — |
| EPS in Rs | -1.24 | -0.3 | -0.56 | -0.32 | -0.28 | -0.24 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 311.14 M | 306.58 M | 295.94 M | 276.24 M |
| Operating Profit | -42.74 M | -57.61 M | -100 M | -140 M |
| Net Profit | -177.97 M | -69.5 M | -118.15 M | -137.4 M |
| EPS in Rs | -2.42 | -0.94 | -1.61 | -1.87 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 502.64 M | 858.93 M | 701.81 M | 752.29 M |
| Total Liabilities | 256.86 M | 493.72 M | 334.89 M | 327.28 M |
| Equity | 245.78 M | 365.21 M | 366.92 M | 425.01 M |
| Current Assets | 169.31 M | 465.65 M | 393.4 M | 427.8 M |
| Current Liabilities | 89.57 M | 325.85 M | 89.03 M | 82.51 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 0.73 M | 14.56 M | -33.08 M | -35.27 M |
| Investing CF | 36.19 M | -22.9 M | 20.29 M | -39.02 M |
| Financing CF | -235.78 M | 151.75 M | 2.73 M | -2.61 M |
| Free CF | -20.82 M | -1.84 M | -47.39 M | -52.68 M |
| Capex | -21.55 M | -16.4 M | -14.31 M | -17.41 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 3.6% | 7.13% | — | — |
| Earnings Growth % | 41.17% | 14.01% | — | — |
| Profit Margin % | -22.67% | -39.92% | -49.74% | — |
| Operating Margin % | -18.79% | -33.79% | -50.68% | — |
| Gross Margin % | 45.92% | 44.55% | 48.21% | — |
| EBITDA Margin % | -3.47% | -19.52% | -33.2% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.